Literature DB >> 25278457

Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

C Alan Howard1, Marcelo A Fernandez-Vina2, Frederick R Appelbaum3, Dennis L Confer4, Steven M Devine5, Mary M Horowitz6, Adam Mendizabal7, Ginna G Laport8, Marcelo C Pasquini6, Stephen R Spellman9.   

Abstract

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) conducts large, multi-institutional clinical trials with the goal of improving the outcomes of hematopoietic cell transplantation (HCT) for patients with life-threatening disorders. Well-designed HCT trials benefit from standardized criteria for defining diagnoses, treatment plans, and graft source selection. In this perspective, we summarize evidence supporting criteria for the selection of related and unrelated adult volunteer progenitor cell donors or umbilical cord blood units. These standardized criteria for graft source selection have been adopted by the BMT CTN to enhance the interpretation of clinical findings within and among future clinical protocols.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic transplantations; Cord blood donor; Recipient; Related donor; Unrelated donor

Mesh：

Substances：

Year:  2014        PMID： 25278457      PMCID： PMC4272893          DOI： 10.1016/j.bbmt.2014.09.017

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


  25 in total

1.  An update to HLA nomenclature, 2010.

Authors:  S G E Marsh; E D Albert; W F Bodmer; R E Bontrop; B Dupont; H A Erlich; M Fernández-Viña; D E Geraghty; R Holdsworth; C K Hurley; M Lau; K W Lee; B Mach; M Maiers; W R Mayr; C R Müller; P Parham; E W Petersdorf; T Sasazuki; J L Strominger; A Svejgaard; P I Terasaki; J M Tiercy; J Trowsdale
Journal:  Bone Marrow Transplant       Date:  2010-03-29       Impact factor: 5.483

2.  Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Authors:  Peter J Shaw; Fangyu Kan; Kwang Woo Ahn; Stephen R Spellman; Mahmoud Aljurf; Mouhab Ayas; Michael Burke; Mitchell S Cairo; Allen R Chen; Stella M Davies; Haydar Frangoul; James Gajewski; Robert Peter Gale; Kamar Godder; Gregory A Hale; Martin B A Heemskerk; John Horan; Naynesh Kamani; Kimberly A Kasow; Ka Wah Chan; Stephanie J Lee; Wing H Leung; Victor A Lewis; David Miklos; Machteld Oudshoorn; Effie W Petersdorf; Olle Ringdén; Jean Sanders; Kirk R Schultz; Adriana Seber; Michelle Setterholm; Donna A Wall; Lolie Yu; Michael A Pulsipher
Journal:  Blood       Date:  2010-07-29       Impact factor: 22.113

3.  The impact of anti-HLA antibodies on unrelated cord blood transplantations.

Authors:  Minoko Takanashi; Yoshiko Atsuta; Koki Fujiwara; Hideki Kodo; Shunro Kai; Hiroyuki Sato; Masatoshi Kohsaki; Hiroshi Azuma; Hidenori Tanaka; Atsuko Ogawa; Kazunori Nakajima; Shunichi Kato
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

4.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

5.  The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.

Authors:  Stephen Spellman; Robert Bray; Sandra Rosen-Bronson; Michael Haagenson; John Klein; Susan Flesch; Cynthia Vierra-Green; Claudio Anasetti
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

6.  Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101.

Authors:  Y Xiao; A M Lazaro; C Masaberg; M Haagenson; C Vierra-Green; S Spellman; S Dakshanamurthy; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2009-04-06

7.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

8.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

9.  High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Authors:  Stefan O Ciurea; Marcos de Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Transplantation       Date:  2009-10-27       Impact factor: 4.939

10.  The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.

Authors:  Karen K Ballen; Roberta J King; Pintip Chitphakdithai; Charles D Bolan; Edward Agura; Robert J Hartzman; Nancy A Kernan
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742
View more
  22 in total

1.  Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen Loci: A GeT-RM Collaborative Project.

Authors:  Maria P Bettinotti; Deborah Ferriola; Jamie L Duke; Timothy L Mosbruger; Nikolaos Tairis; Lawrence Jennings; Lisa V Kalman; Dimitri Monos
Journal:  J Mol Diagn       Date:  2018-06-26       Impact factor: 5.568

2.  Accurate Typing of Human Leukocyte Antigen Class I Genes by Oxford Nanopore Sequencing.

Authors:  Chang Liu; Fangzhou Xiao; Jessica Hoisington-Lopez; Kathrin Lang; Philipp Quenzel; Brian Duffy; Robi D Mitra
Journal:  J Mol Diagn       Date:  2018-04-03       Impact factor: 5.568

Review 3.  The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation.

Authors: 
Journal:  Biol Blood Marrow Transplant       Date:  2016-07-11       Impact factor: 5.742

4.  Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned.

Authors:  B S Sorensen; J Szer; B Shaw; M Korhonen; T Mengling; M Fechter; H Elmoazzen; B Lindberg; J Chapman; J M Nørgaard; L Foeken; W Y K Hwang; B Nielsen
Journal:  Bone Marrow Transplant       Date:  2016-03-14       Impact factor: 5.483

5.  Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

Authors:  Armin Rashidi; Mehdi Hamadani; Mei-Jie Zhang; Hai-Lin Wang; Hisham Abdel-Azim; Mahmoud Aljurf; Amer Assal; Ashish Bajel; Asad Bashey; Minoo Battiwalla; Amer M Beitinjaneh; Nelli Bejanyan; Vijaya Raj Bhatt; Javier Bolaños-Meade; Michael Byrne; Jean-Yves Cahn; Mitchell Cairo; Stefan Ciurea; Edward Copelan; Corey Cutler; Andrew Daly; Miguel-Angel Diaz; Nosha Farhadfar; Robert P Gale; Siddhartha Ganguly; Michael R Grunwald; Theresa Hahn; Shahrukh Hashmi; Gerhard C Hildebrandt; H Kent Holland; Nasheed Hossain; Christopher G Kanakry; Mohamed A Kharfan-Dabaja; Nandita Khera; Yener Koc; Hillard M Lazarus; Jong-Wook Lee; Johan Maertens; Rodrigo Martino; Joseph McGuirk; Reinhold Munker; Hemant S Murthy; Ryotaro Nakamura; Sunita Nathan; Taiga Nishihori; Neil Palmisiano; Sagar Patel; Joseph Pidala; Rebecca Olin; Richard F Olsson; Betul Oran; Olov Ringden; David Rizzieri; Jacob Rowe; Mary Lynn Savoie; Kirk R Schultz; Sachiko Seo; Brian C Shaffer; Anurag Singh; Melhem Solh; Keith Stockerl-Goldstein; Leo F Verdonck; John Wagner; Edmund K Waller; Marcos De Lima; Brenda M Sandmaier; Mark Litzow; Dan Weisdorf; Rizwan Romee; Wael Saber
Journal:  Blood Adv       Date:  2019-06-25

6.  Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.

Authors:  Eric Davis; Sean Devlin; Candice Cooper; Melissa Nhaissi; Jennifer Paulson; Deborah Wells; Andromachi Scaradavou; Sergio Giralt; Esperanza Papadopoulos; Nancy A Kernan; Courtney Byam; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-26       Impact factor: 5.742

7.  ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.

Authors:  Aaron C Logan; Zhiyu Wang; Kamran Alimoghaddam; Ruby M Wong; Tze Lai; Robert S Negrin; Carl Grumet; Brent R Logan; Mei-Jie Zhang; Stephen R Spellman; Stephanie J Lee; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-05       Impact factor: 5.742

8.  YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.

Authors:  B Kornblit; T Wang; S J Lee; S R Spellman; X Zhu; K Fleischhauer; C Müller; M R Verneris; K Müller; J S Johansen; L Vindelov; P Garred
Journal:  Bone Marrow Transplant       Date:  2016-07-18       Impact factor: 5.483

9.  Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation.

Authors:  Rebeca Bailén; Mi Kwon; María Jesús Pascual-Cascón; Christelle Ferrà; Jaime Sanz; Anabel Gallardo-Morillo; Abel García-Sola; Anna Torrent; María José Jiménez-Lorenzo; José Luis Piñana; Juan Montoro; Gillen Oarbeascoa; Nieves Dorado; Ignacio Gómez-Centurión; Cristina Muñoz; Carolina Martínez-Laperche; Javier Anguita; Ismael Buño; José Luis Díez-Martín
Journal:  Ann Hematol       Date:  2020-11-02       Impact factor: 3.673

10.  KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.

Authors:  Daniel Weisdorf; Sarah Cooley; Tao Wang; Elizabeth Trachtenberg; Cynthia Vierra-Green; Stephen Spellman; Jennifer A Sees; Ashley Spahn; Jenny Vogel; Todd A Fehniger; Ann E Woolfrey; Steven M Devine; Maureen Ross; Edmund K Waller; Ronald M Sobecks; Joseph McGuirk; Betul Oran; Sherif S Farag; Tsiporah Shore; Koen Van Besien; Steven G E Marsh; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller
Journal:  Blood Adv       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.